Product
Faster Aspart
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 1Indication
Type 2Clinical trial
A Trial Investigating the Pharmacokinetic Properties of Fast-acting Insulin Aspart in Chinese Subjects With Type 1 Diabetes or Type 2 DiabetesStatus: Completed, Estimated PCD: 2023-04-25
Clinical trial
A Study Investigating the Pharmacokinetic and Pharmacodynamic Properties and Safety and Tolerability of Three Formulations of NNC0471-0119 When Administered as One Bolus in a Continuous Subcutaneous Insulin Infusion Regimen in Participants With Type 1 DiabetesStatus: Completed, Estimated PCD: 2022-08-29